Vertex Pharmaceuticals (VRTX) Selling, General & Administrative (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Selling, General & Administrative of $582.2 million for Q2 2026, up 37.1% from $424.6 million a year earlier and up 17.9% from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Selling, General & Administrative (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Vertex Pharmaceuticals was $2.01 billion, up 27.9% year-over-year; for FY2025, it came in at $1.75 billion, up 19.7% from FY2024.
- Annual Selling, General & Administrative has increased for 11 consecutive years, with a five-year compound annual growth rate of 17.9% (FY2020 to FY2025).
- In prior years, Vertex Pharmaceuticals' Selling, General & Administrative was $1.46 billion in FY2024 (+28.8%), $1.14 billion in FY2023 (+20.3%), $944.7 million in FY2022 (+12.5%) and $840.1 million in FY2021 (+9.0%).
- The Q2 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to Q1 2009.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last 47 quarters, with growth averaging 22.9% over the last eight quarters.
- Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 2.3% (Q4 2024) to 42.1% (Q1 2024).
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $493.7 million (Q1 2026), $487 million (Q4 2025) and $445.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 1.83 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 582.20 Mn |
| Mar 31, 2026 | 493.70 Mn |
| Dec 31, 2025 | 487.00 Mn |
| Sep 30, 2025 | 445.10 Mn |
| Jun 30, 2025 | 424.60 Mn |
| Mar 31, 2025 | 396.40 Mn |
| Dec 31, 2024 | 377.60 Mn |
| Sep 30, 2024 | 371.80 Mn |
| Jun 30, 2024 | 372.20 Mn |
| Mar 31, 2024 | 342.70 Mn |
| Dec 31, 2023 | 369.10 Mn |
| Sep 30, 2023 | 263.80 Mn |
| Jun 30, 2023 | 262.60 Mn |
| Mar 31, 2023 | 241.10 Mn |
| Dec 31, 2022 | 267.40 Mn |
| Sep 30, 2022 | 246.80 Mn |
| Jun 30, 2022 | 215.30 Mn |
| Mar 31, 2022 | 215.20 Mn |
| Dec 31, 2021 | 255.20 Mn |
| Sep 30, 2021 | 198.20 Mn |
API Access
Vertex Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();